Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Takeda to begin cardiovascular outcomes trial for alogliptin to treat type 2 diabetes
Takeda to begin cardiovascular outcomes trial for alogliptin to treat type 2 diabetes
Takeda to begin cardiovascular outcomes trial for alogliptin to treat type 2 diabetes
Submitted by
admin
on August 29, 2009 - 11:23am
Source:
Pharmabiz
News Tags:
Takeda
alogliptin
diabetes
Headline:
Takeda to begin cardiovascular outcomes trial for alogliptin to treat type 2 diabetes
Do Not Allow Advertisers to Use My Personal information
